FDA Expands Pfizer COVID Booster, Opens Extra Dose To Age 16 And Up

The FDA has extended emergency use authorization for Pfizer's COVID-19 booster to include 16 and 17-year-olds, following a study showing increased protection against the Omicron variant. Despite this, only 25% of the eligible U.S. population has received a booster. Experts emphasize the importance of boosters and masks, particularly N95s, in combating the variant. The World Health Organization warns Omicron could alter the pandemic's trajectory, and experts call for redefining 'fully vaccinated' to mean three doses.

What recent change did the FDA make regarding COVID-19 boosters?

• Extended booster eligibility to 16 and 17-year-olds

• Approved a new vaccine for children

• Restricted booster shots to high-risk individuals

• Authorized boosters for all age groups

How much did the Pfizer booster improve protection against the Omicron variant?

• 50-fold

• 25-fold

• 15-fold

• 10-fold

What is the current status of booster availability for younger children?

• No timeline yet

• Expected next month

• Available now

• Available only in certain states

What did the World Health Organization say about the Omicron variant?

• It is the final variant

• It could change the course of the pandemic

• It is less severe than Delta

• It is not a concern

What type of mask is recommended for the best protection against variants?

• Cloth mask

• Surgical mask

• N95 or KN95 mask

• Face shield